近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Capewell, P., Clucas, C., DeJesus, E., Kieft, R., Hajduk, S., Veitch, N., Steketee, P.C., Cooper, A., Weir, W., and MacLeod, A. (2013) The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense. PLoS Pathogens, 9(10), e1003686. (doi:10.1371/journal.ppat.1003686)
Bullard, W., Kieft, R., Capewell, P., Veitch, N.J., Macleod, A., and Hajduk, S. (2012) Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors. Virulence, 3(1), pp. 72-76. (doi:10.4161/viru.3.1.18295)
Bullard, W., Kieft, R., Capewell, P., Veitch, N.J., MacLeod, A., and Hajduk, S.L. (2012) Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum. Virulence, 3(1), pp. 72-76. (doi:10.4161/viru.3.1.18295)
Capewell, P., Veitch, N.J., Turner, C.M.R., Raper, J., Berriman, M., Hajduk, S.L., and MacLeod, A. (2011) Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by Trypanolytic factor 1. PLoS Neglected Tropical Diseases, 5(9), e1287. (doi:10.1371/journal.pntd.0001287)
Kieft, R., Capewell, P., Turner, C.M.R., Veitch, N.J., MacLeod, A., and Hajduk, S. (2010) Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor. Proceedings of the National Academy of Sciences of the United States of America, 107(37), pp. 16137-16141. (doi:10.1073/pnas.1007074107)
Veitch, N.J., Johnson, P.C.D., Trivedi, U., Terry, S., Wildridge, D., and MacLeod, A. (2010) Digital gene expression analysis of two life cycle stages of the human-infective parasite, Trypanosoma brucei gambiense reveals differentially expressed clusters of co-regulated genes. BMC Medical Genomics, 11, p. 124. (doi:10.1186/1471-2164-11-124)
Naula, C., Alibu, V., Brock, J., Veitch, N.J., Burchmore, R.J.S., and Barrett, M. (2007) A new erythrose 4-phosphate dehydrogenase coupled assay for transketolase. Journal of Biochemical and Biophysical Methods, 70(6), pp. 1185-1187. (doi:10.1016/j.jprot.2007.11.002)
Shelbourne, P.F., Keller-McGandy, C., Bi, W.L., Yoon, S.R., Dubeau, L., Veitch, N.J., Vonsattel, J.P., Wexler, N.S., Arnheim, N., and Augood, S.J. (2007) Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Human Molecular Genetics, 16(10), pp. 1133-1142. (doi:10.1093/hmg/ddm054)
Veitch, N.J., Ennis, M., McAbney, J.P., Shelbourne, P.F., and Monckton, D.G. (2007) Inherited CAG center dot CTG allele length is a major modifier of somatic mutation length variability in Huntington disease. DNA Repair, 6(6), pp. 789-796. (doi:10.1016/j.dnarep.2007.01.002)
Veitch, N.V., Maugeri, D.A., Cazzulo, J.J., Lindqvist, Y., and Barrett, M.P. (2004) Transketolase from Leishmania mexicana has a dual subcellular localization. Biochemical Journal, 382(2), pp. 759-767. (doi:10.1042/BJ20040459)